Press Releases
Prolacta Bioscience, the nation’s leading provider of human milk-based neonatal nutritional products to hospitals, recognizes and honors the clinical expertise, dedication and commitment to care of neonatal nurses during National Nurse Week (May 6-12, 2017) with its support of four nursing conferences and the launch of a national Nursing Practice Advisory Council (NPAC).
The NPAC is an advisory group composed of neonatal nursing leaders who are passionate about human milk science and nutrition. Their mission is to share clinical expertise and emerging research to affect clinical practice, education and outcomes in the neonatal intensive care unit (NICU) population. The council will develop and deliver educational resources and support, for the neonatal nurse community and other clinicians, on the use of an exclusive human milk diet (EHMD) and other human milk practices.
Advisory council members include both nurse practitioners and nurse managers, who are recognized nationally or globally as influencers, and who are actively involved in their professional associations. Founding members include:
“I’m honored to be involved with the national Nursing Practice Advisory Council, and to serve among an impressive group of nurses and nurse managers in the neonatal nurse community,” said Amy Paradis, NNP. “Our goal is to be a resource for nurses, nurse practitioners, clinicians, and neonatologists nationwide, and to educate and help them implement and maximize the use of an exclusive human milk diet to improve outcomes for premature babies in the NICU.”
Prolacta Bioscience is a longtime supporter of several educational and professional associations in the nursing field. Its 2017 sponsorships include:
“We are honored to participate in an impressive lineup of conferences that provide education and support to neonatal nurses nationwide,” said Scott Elster, CEO of Prolacta. “NICU nurses are on the front line, day in and day out, caring for the most fragile babies in the NICU, and they have our full appreciation and support for their tireless efforts.”
Prolacta Bioscience, Inc. is a privately held life sciences company dedicated to Advancing the Science of Human Milk®. The company pioneered the development of human milk-based neonatal nutritional products to meet the needs of critically ill, premature infants in the NICU. Prolacta leads the industry in the quality and safety of nutritional products made from donor breast milk and operates the first and only pharmaceutical-grade manufacturing facility for the processing of human breast milk.